Two year save outcomes: 2.0 mg Ranibizumab for Recalcitrant Neovascular AMD

Research output: Contribution to journalLetterpeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Two year save outcomes: 2.0 mg Ranibizumab for Recalcitrant Neovascular AMD'. Together they form a unique fingerprint.